Qingmei Guo

Dr. Qingmei Guo


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2022 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Closed access
PDF file
SZShi-Yao Zhang
Shi-Yao Zhang
XSXiao-Lei Sun
Xiao-Lei Sun
XYXing-Liang Yang
Xing-Liang Yang
PSPeng-Liang Shi
Peng-Liang Shi
LXLing-Chuan Xu
Ling-Chuan Xu
QGQingmei Guo
Qingmei Guo
Crataegus pinnatifida (C. pinnatifida), including C. pinnatifida Bge. and its variant C. pinnatifida Bge. var. major N, E. Br., has traditionally been used as a homologous plant for traditional medicine and food in ethnic medical systems in China. Crataegus pinnatifida, especially its fruit, has been used for more than 2000 years to treat indigestion, stagnation of meat, hyperlipidemia, blood stasis, heart tingling, sores, etc. This review aimed to provide a systematic summary on the botany, traditional uses, phytochemistry, pharmacology and clinical applications of C. pinnatifida. This plant contains flavonoids, phenylpropanoids, terpenoids, organic acids, saccharides and essential oils. Experimental studies showed that it has hypolipidemic, antimyocardial, anti-ischemia, antithrombotic, anti-atherosclerotic, anti-inflammatory, antineoplastic neuroprotective activity, etc. Importantly, it has good effects in treating diseases of the digestive system and cardiovascular and cerebrovascular systems. There is convincing evidence from both in vitro and in vivo studies supporting the traditional uses of C. pinnatifida. However, multitarget network pharmacology and molecular docking technology should be used to study the interaction between the active ingredients and targets of C. pinnatifida. Furthermore, exploring the synergy of C. pinnatifida with other Chinese medicines to provide new understanding of complex diseases may be a promising strategy.

4 September 2024 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
PSPengliang Shi
Pengliang Shi
BZBingqing Zheng
Bingqing Zheng
SZShiyao Zhang
Shiyao Zhang
QGQingmei Guo
Qingmei Guo
Introduction: Morroniside (Mor) is a bioactive compound found in Corni Fructus (CF) [Cornaceae; Cornus officinalis Siebold & Zucc.], which has been used as medicine and food in China, Korea, and Japan for over 2,000 years. This review summarizes recent progress on Mor, specifically focusing on its distribution, isolation, detection, and various pharmacological effects.Methods: A literature survey on Mor was conducted using electronic databases such as PubMed, ScienceDirect, CNKI, and Google Scholar. After removing TCM prescription-related standards, medicinal herb processing-related research, and other irrelevant works of literature, we obtained relevant information on Mor’s biological and pharmacological properties.Results: The main conclusions are as follows: Mor is widely distributed in the plant kingdom; the methods for extracting and isolating Mor are well established; and the technology for detecting it is accurate. Mor exhibits numerous pharmacological effects. Along with CF, Mor has shown renoprotective effects against diabetes, hepatoprotective effects against diabetes, triptolide, and nonalcoholic steatohepatitis, and boneprotective effects against osteoporosis and osteoarthritis. In addition, researchers have also explored other pharmacological effects of Mor, including neuroprotective effects against focal cerebral ischemia, spinal cord injury, and Alzheimer’s disease; cardioprotective effects against acute myocardial infarction; protection of the digestive system from gastritis, inflammatory bowel disease, and colitis; protection of the skin by promoting hair growth, wound healing, and flap survival; and protection of the lungs from acute lung injury and pulmonary fibrosis. Moreover, Mor has anti-obesity effects, anti-inflammatory effects in the eye, and improves follicular development.Discussion: Overall, this review provides a comprehensive understanding of the pharmacological effects of Mor, from which the limitations of the current research can be understood, which will help facilitate future research.

22 February 2025 in Phytomedicine
Verified
Journal Article
Closed access
PSPengLiang Shi
PengLiang Shi
BZBingQing Zheng
BingQing Zheng
YCYan Cao
Yan Cao
GNGuoZhong Niu
GuoZhong Niu
QGQingmei Guo
Qingmei Guo

24 March 2023 in Molecules
Verified
Journal Article
Open access
PDF file
YSYizheng Sun
Yizheng Sun
XLXiaoyan Liu
Xiaoyan Liu
XFXiaojie Fu
Xiaojie Fu
WXWei Xu
Wei Xu
QGQingmei Guo
Qingmei Guo
Youbo ZhangYoubo Zhang
Youbo Zhang
Panax ginseng (P. ginseng), the dried root and rhizome of P. ginseng C. A. Meyer, is widely used in many fields as dietary supplements and medicine. To characterize the chemical constituents in P. ginseng cultivated in different growth environments, a UPLC-TOF-MS method was established for qualitative analysis. Four hundred and eight ginsenosides, including 81 new compounds, were characterized in P. ginseng from different regions. Among the detected compounds, 361 ginsenosides were recognized in P. ginseng cultivated in the region of Monsoon Climate of Medium Latitudes, possessing the largest amount of ginsenosides in all samples. Furthermore, 41 ginsenosides in 12 batches of P. ginsengs were quantified with a UPLC-MRM-MS method, and P. ginsengs from different regions were distinguished via chemometric analysis. This study showed that the different environments have a greater influence on P. ginseng, which laid a foundation for further quality control of the herb.

22 February 2023 in Molecules
Verified
Journal Article
Open access
PDF file
YSYizheng Sun
Yizheng Sun
XFXiaojie Fu
Xiaojie Fu
YQYing Qu
Ying Qu
LCLihua Chen
Lihua Chen
XLXiaoyan Liu
Xiaoyan Liu
Youbo ZhangYoubo Zhang
Youbo Zhang
To compare the chemical distinctions of Panax ginseng Meyer in different growth environments and explore the effects of growth-environment factors on P. ginseng growth, an ultra-performance liquid chromatography–tandem triple quadrupole time-of-flight mass spectrometry (UPLC-Triple-TOF-MS/MS) was used to characterize the ginsenosides obtained by ultrasonic extraction from P. ginseng grown in different growing environments. Sixty-three ginsenosides were used as reference standards for accurate qualitative analysis. Cluster analysis was used to analyze the differences in main components and clarified the influence of growth environment factors on P. ginseng compounds. A total of 312 ginsenosides were identified in four types of P. ginseng, among which 75 were potential new ginsenosides. The number of ginsenosides in L15 was the highest, and the number of ginsenosides in the other three groups was similar, but it was a great difference in specie of ginsenosides. The study confirmed that different growing environments had a great influence on the constituents of P. ginseng, and provided a new breakthrough for the further study of the potential compounds in P. ginseng.

20 January 2012 in Chinese Journal of Natural Medicines
Verified
Journal Article
Closed access
QZQi-Tao Zhao
Qi-Tao Zhao
QGQingmei Guo
Qingmei Guo
PWPeng Wang
Peng Wang
QWQian Wang
Qian Wang